HIV Infections
📧 Sign up to get email alerts when something new happens for HIV Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults [Phase 1]
Phase 1 trial assessing safety and serum concentrations of the human monoclonal antibody VRC-HIVMAB075-00-AB (VRC07-523LS) in healthy, HIV-u…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND) [Phase 4]
Phase 4 clinical trial update on integrase and maraviroc intensification for HIV-associated neurocognitive dysfunction shows completed study…
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients [Phase 4]
Phase 4 clinical trial evaluating sulforaphane to modulate inflammatory and metabolic changes in virally suppressed HIV patients.
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254 [Phase 1]
Phase 1 pharmacokinetics and metabolism study of 14C-labeled GSK3640254 completed.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study [Phase 1, Phase 2]
Phase 1/2 pharmacokinetic study of darunavir/ritonavir with rosuvastatin completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US) [Phase 3]
Phase 3 trial update assessing best implementation practices for injectable cabotegravir + rilpivirine in the United States; study completed…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus [Phase 1]
Phase 1 trial evaluating HIV-1 gp120 protein vaccine in HIV-uninfected adults with quiescent systemic lupus erythematosus has completed with…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants [Phase 3]
Clinical trial update indicating continued access to etravirine (ETR) for treatment-experienced HIV-1 infected participants in Phase 3; stud…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cART [Phase 1, Phase 2]
Clinical trial update evaluating safety and immunotherapeutic activity of cemiplimab (anti-PD-1) in people with HIV on suppressive cART; the…
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents [Phase 1, Phase 2]
Phase 1/2 trial assessing pharmacokinetics, safety, and tolerability of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate i…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy [Phase 2]
Phase 2 pharmacokinetic study evaluating double-dose levonorgestrel emergency contraception with efavirenz-based ART or rifampicin-containin…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Optimizing the Delivery of HIV nPEP [Phase 2]
Phase 2 clinical trial update for optimizing delivery of HIV nonoccupational post-exposure prophylaxis (nPEP).
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants [Phase 3]
Phase 3 trial comparing dolutegravir-containing versus efavirenz-containing ART in HIV-1-infected pregnant women and their infants has compl…
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the safety and activity of the oral HIV entry inhibitor AMD11070 in HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients [Phase 2]
A Phase 2 clinical trial evaluating the effectiveness and immune response to HIV vaccination followed by treatment interruption in HIV-infec…
-
CLINICAL_TRIALS research · 2021-11-09Clinical Trial Update: Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand [Phase 1, Phase 2]
Clinical trial update on safety and pharmacokinetics of a fixed-dose combination of zidovudine, lamivudine, and nevirapine in HIV-infected c…
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women [Phase 2]
Phase 2 clinical trial update for vaginal gels BufferGel and PRO 2000/5 aimed at preventing HIV infection in women; study completed.
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week [Phase 3]
Phase 3 trial evaluating a dual therapy regimen in HIV patients comparing 4 days per week versus 7 days per week; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients [Phase 3]
Phase 3 randomized trial comparing daily versus thrice-weekly Trimethoprim/Sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma [Phase 3]
Phase 3 trial evaluating AZT in HIV-infected patients with AIDS-related Kaposi's sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS [Phase 3]
Phase 3 trial comparing trimetrexate with leucovorin rescue to sulfamethoxazole-trimethoprim for Pneumocystis jirovecii pneumonia (PCP) in A…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides [Phase 3]
Phase 3 randomized trial comparing daily dapsone vs daily atovaquone for Pneumocystis jirovecii pneumonia prophylaxis in HIV-infected patien…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Study of Disease Progression and Anti-HIV Treatments [Phase 2]
Phase 2 clinical trial update evaluating disease progression and anti-HIV treatments in HIV infections.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine [Phase 2]
Phase 2 trial update on antiviral activity and resistance of lamivudine in combination with other nucleoside analogs for HIV infections.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks [Phase 2]
Phase 2 trial evaluating three drug combinations in HIV-infected patients with prior Zidovudine exposure (more than 12 weeks).